SILVA, F.R.O.YOSHITO, W.K.COSENTINO, I.C.BRESSIANI, A.H.A.LIMA, N.B.2017-03-212017-03-21SILVA, F.R.O.; YOSHITO, W.K.; COSENTINO, I.C.; BRESSIANI, A.H.A.; LIMA, N.B. Synthesis and characterization of new crystalline mesoporous beta-tricalcium phosphate nanoparticles. In: CONGRESSO BRASILEIRO DE ENGENHARIA E CIENCIA DOS MATERIAIS, 22., 06-10 de novembro, 2016, Natal, RN. <b>Resumo...</b> p. 1699. Disponível em: http://repositorio.ipen.br/handle/123456789/27241.http://repositorio.ipen.br/handle/123456789/27241Calcium phosphates, including hydroxyapatite [HA, Ca10 (PO4)6(OH)2] and beta-tricalcium phosphate [B-TCP, Ca3(PO4)2], are the main mineral component of bone tissue and teeth. The synthetic calcium phosphates are of special interest in medicine because of their biocompatibility, bioactivity and non-toxicity. B-TCP is advantageous to HA for drug delivery system due to their high solubility and controllable bioresorption rate. To obtain B-TCP, the literature reports the transformation of calcium deficient hydroxyapatite (CDHA) to ?-TCP since it couldnot be synthesized directly in aqueous solution, until now. For the first time, B-TCP have been successfully synthesized by wet precipitation method at room temperature with a Ca/P molar ratio equal to 1.5 and pH at 6. The present work is concerned with the preparation of B-TCP and it characterization through XRD, BET and TEM analysis. The results showed well-characterized peaks of crystalline pure B-TCP (JCPDS 09-0169) for the dried powder, with a high BET surface area of 574 ± 7 (m2/g). The TEM micrographs exhibits mesoporous structure, which is suitable as a drug carrier.1699openAccessResumo de eventos científicoshttps://orcid.org/0000-0002-6444-9224https://orcid.org/0000-0001-5649-7683